Azerbaijan vs Slovenia: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Azerbaijan
52.0%
in 2024
Slovenia
56.0%
in 2024
Azerbaijan rank
139th
Slovenia rank
137th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Azerbaijan
- Slovenia
How they compare
Slovenia currently reports 56.0% against 52.0% in Azerbaijan, a difference of 4.0%.
That makes Slovenia's figure about 1.1 times Azerbaijan's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Azerbaijan ahead.
Azerbaijan ranks 139th and Slovenia ranks 137th of 146 countries.
Across the 2 decades both report, Azerbaijan averaged higher in 1 and Slovenia in 1.
Head to head by decade
| Decade | Azerbaijan | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.6% | 56.0% | 17.6% | Azerbaijan |
| 2020s | 50.6% | 60.6% | 10.0% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Azerbaijan or Slovenia?
- Slovenia, at 56.0% against 52.0% in Azerbaijan as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Azerbaijan and Slovenia?
- 4.0%, with Slovenia ahead.
- How many years of comparable data are there for Azerbaijan and Slovenia?
- 10 years are reported by both, from 2015 to 2024.
- How do Azerbaijan and Slovenia rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Azerbaijan ranks 139th and Slovenia ranks 137th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.